Phylo Partners With Bayer on Biomni Lab AI Agents for Drug Research

Phylo, Inc. announced on October 22, 2026, a partnership with Bayer to deploy Biomni Lab, Phylo's agentic AI platform, to accelerate scientific research and evaluation, with Bayer scientists gaining full access for literature and omics evidence workflows in drug discovery. The Bayer Partnership Under the agreement, Phylo will provide Bayer with full access to its agentic platform. Phylo says the platform helps Bayer scientists bring together scientific literature, biomedical data, and...